PER 34.1% 8.9¢ percheron therapeutics limited

Sarepta eyes multiple sclerosis gene therapy, page-13

  1. 173 Posts.
    lightbulb Created with Sketch. 37
    Sarepta went to $1 BILLION valuation after positive phase 2 results so why not ANP too ? that would mean around $2.20 per share for ANP .Whatever its the HOTTEST DMD GEM out there . STRONG BUY


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.